{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:17:04Z","timestamp":1790299024690,"version":"4.1.0"},"reference-count":46,"publisher":"Cambridge University Press (CUP)","issue":"12","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"unspecified","delay-in-days":2533,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS spectr."],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title><jats:bold>Introduction<\/jats:bold><\/jats:title><jats:p>Comorbid anxiety disorders are frequently encountered in psychoses and mainly assessed during the hospitalization.<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:bold>Methods<\/jats:bold><\/jats:title><jats:p>Comorbidity was investigated in 98 patients with schizophrenia, schizoaffective, or bipolar disorder, previously hospitalized for psychotic symptoms. Assessments, including Structured Clinical Interview for the<jats:italic>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition<\/jats:italic>, Brief Psychiatric Rating Scale, and Clinical Global Impressions Scale, were performed during hospitalization (t0) and subsequently in a phase of remission (t1). Comorbidity was assessed at t1 only.<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:bold>Results<\/jats:bold><\/jats:title><jats:p>One or more comorbid anxiety diagnoses were made in 46 (46.9%) patients. Of these, 15 (32.6%) received multiple anxiety diagnoses, while 31 (67.4%) single anxiety diagnoses. Schizophrenic patients had a rate of social anxiety disorder (SAD) higher (<jats:italic>P<\/jats:italic>&lt;.05) than the others. Patients assessed with panic disorder or with obsessive-compulsive disorder at t1 showed significantly greater severity of illness at t0; patients with SAD demonstrated greater severity at t1. No significant differences in the rates of individual anxiety disorders were found in patients treated with typical or atypical antipsychotics or with both.<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:bold>Conclusion<\/jats:bold><\/jats:title><jats:p>Anxiety disorders, particularly obsessive-compulsive disorder, panic disorder and SAD, seem to be frequently comorbid in remitted psychotic patients; SAD would be more prevalent in schizophrenia and might negatively impact the course of the illness.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s1092852900015704","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T04:56:14Z","timestamp":1470113774000},"page":"913-919","source":"Crossref","is-referenced-by-count":41,"title":["Comorbidity with Axis I Anxiety Disorders in Remitted Psychotic Patients 1 Year After Hospitalization"],"prefix":"10.1017","volume":"12","author":[{"given":"Antonio","family":"Ciapparelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemma","family":"Paggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Marazziti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Carmassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Taponecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Massimetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Dell'Osso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"S1092852900015704_ref046","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(03)00039-3"},{"key":"S1092852900015704_ref045","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0203"},{"key":"S1092852900015704_ref043","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1176\/ajp.156.5.799","article-title":"Olanzapine-induced obsessive-compulsive disorder","volume":"156","author":"Mottard","year":"1999","journal-title":"Am J Psychiatry"},{"key":"S1092852900015704_ref042","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.11.1626f"},{"key":"S1092852900015704_ref040","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199410000-00014"},{"key":"S1092852900015704_ref038","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.5.687"},{"key":"S1092852900015704_ref036","first-page":"439","article-title":"Emergence of obsessive-compulsive symptoms during treatment with clozapine","volume":"53","author":"Baker","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"S1092852900015704_ref035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2004.12.007"},{"key":"S1092852900015704_ref034","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0813"},{"key":"S1092852900015704_ref033","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.1999"},{"key":"S1092852900015704_ref030","doi-asserted-by":"publisher","DOI":"10.1080\/j.1440-1614.2004.01487.x"},{"key":"S1092852900015704_ref028","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.172.4.308"},{"key":"S1092852900015704_ref027","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(94)90022-1"},{"key":"S1092852900015704_ref022","first-page":"1","article-title":"La psicopatologia cognitiva del rimuginio","volume":"9","author":"Sassaroli","year":"2003","journal-title":"It J Behav Cogn Psychother"},{"key":"S1092852900015704_ref021","volume-title":"Repertorio delle scale di valutazione in psichiatria","author":"Conti","year":"1999"},{"key":"S1092852900015704_ref020","first-page":"218","volume-title":"ECDEU Assessment Manual for Psychopharmacology. revised (DHEW Publ No ADM 76-338)","author":"Guy","year":"1976"},{"key":"S1092852900015704_ref026","first-page":"18","article-title":"Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia","volume":"18","author":"Addington","year":"1993","journal-title":"J Psychiatry Neurosci"},{"key":"S1092852900015704_ref018","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition. SCID-I\/P, Version 2.0","author":"First","year":"1994"},{"key":"S1092852900015704_ref015","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.1.53"},{"key":"S1092852900015704_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00292-X"},{"key":"S1092852900015704_ref011","doi-asserted-by":"publisher","DOI":"10.1177\/070674379904400510"},{"key":"S1092852900015704_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.02.004"},{"key":"S1092852900015704_ref008","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.4.592"},{"key":"S1092852900015704_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2004.09.003"},{"key":"S1092852900015704_ref004","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(99)00151-6"},{"key":"S1092852900015704_ref009","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2004.07.009"},{"key":"S1092852900015704_ref003","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1176\/ajp.156.3.474","article-title":"Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features","volume":"156","author":"Cassano","year":"1999","journal-title":"Am J Psychiatry"},{"key":"S1092852900015704_ref001","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-004-0074-0"},{"key":"S1092852900015704_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(91)90025-8"},{"key":"S1092852900015704_ref031","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.178.5.420"},{"key":"S1092852900015704_ref013","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830110060007"},{"key":"S1092852900015704_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(00)00126-2"},{"key":"S1092852900015704_ref023","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0204"},{"key":"S1092852900015704_ref025","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198001000-00004"},{"key":"S1092852900015704_ref029","doi-asserted-by":"publisher","DOI":"10.1007\/s127-002-8207-y"},{"key":"S1092852900015704_ref032","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(99)80729-9"},{"key":"S1092852900015704_ref012","doi-asserted-by":"publisher","DOI":"10.1002\/da.10083"},{"key":"S1092852900015704_ref005","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1212"},{"key":"S1092852900015704_ref037","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1176\/ajp.150.5.836a","article-title":"Development of obsessive-compulsive symptoms during clozapine treatment","volume":"150","author":"Patel","year":"1993","journal-title":"Am J Psychiatry"},{"key":"S1092852900015704_ref002","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033336"},{"key":"S1092852900015704_ref024","doi-asserted-by":"publisher","DOI":"10.3109\/00048679809062708"},{"key":"S1092852900015704_ref044","doi-asserted-by":"publisher","DOI":"10.1159\/000012321"},{"key":"S1092852900015704_ref039","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1176\/ajp.151.11.1714a","article-title":"Risperidone, serotoninergic mechanisms, and obsessive-compulsive symptoms in schizophrenia","volume":"151","author":"Kopala","year":"1994","journal-title":"Am J Psychiatry"},{"key":"S1092852900015704_ref016","doi-asserted-by":"publisher","DOI":"10.1037\/0021-843X.112.3.415"},{"key":"S1092852900015704_ref019","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"S1092852900015704_ref041","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1176\/ajp.155.6.855","article-title":"Worsening of obsessive-compulsive symptoms following treatment with olanzapine","volume":"155","author":"Morrison","year":"1998","journal-title":"Am J Psychiatry"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852900015704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:58:07Z","timestamp":1749034687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852900015704\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1092852900015704"],"URL":"https:\/\/doi.org\/10.1017\/s1092852900015704","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}